Get in touch
Questions about growing, workshops, the cooperative or partnerships? Send us a message and we will reply by email.
Prefer email? Write to erasmus@evec.org.gr
EVEC Microgreens
Molecular modeling and identification of flax microgreens lignans as novel prostate cancer target inhibitors
One of the most common types of cancer is prostate cancer (PCa) and its prevalence rate is increasing in old men of ~70 years. In pharmacotherapy, natural
Mudassir Lawal, Neeta Raj Sharma, Awadhesh Kumar Verma, Gurmeen Rakhra
Journal of Applied Biology & Biotechnology · 2025 · https://doi.org/10.7324/JABB.2025.205522
Abstract
One of the most common types of cancer is prostate cancer (PCa) and its prevalence rate is increasing in old men of ~70 years. In pharmacotherapy, natural compounds and their structural analogs have been used for cancer treatment. Several studies have demonstrated the therapeutic potential of Linum usitatissimum, commonly known as flax, in treating various cancers. However, the specific mechanisms by which flax-derived compounds act on PCa remain unclear. This study aims to fill this gap by identifying and evaluating the bioactive compounds in flax microgreens. The GCMS analysis was carried out using a Shimadzu (GCMS-TQ8040 NX). The instrument temperature was set from 50°C up to 300°C for 37 minutes to give a 100% total peak area. The molecular docking studies were carried out using AutoDock tools 4.2 version software. The ADMET properties were predicted and analysed using SWISSADME online (http://www.swissadme.ch/) and ProTox-3.0 online (https://tox.charite.de/protox3/index.php?site) prediction tools. GC-MS analysis identified 58 phytocompounds in the methanolic extracts of flax microgreens. Among these, CID11002708 and CID290541 exhibited the highest binding affinities to PCa target proteins. The ADME/T result shows the compounds have low toxicity and specific metabolic characteristics. Taking into account, the results of molecular docking and ADMET evaluation, it can be concluded that CID11002708 and CID290541 hold promise as novel inhibitors for the treatment of PCa. The current results can further be validated via in vitro and in vivo studies.
Licence and reuse
| Licence | CC-BY-NC-SA-4.0 |
|---|---|
| May we host this PDF? | Yes |
| May we publish a plain-language summary? | Yes — this licence permits adaptations. |
| Commercial use permitted? | No — non-commercial use only |
| Share-alike required? | Yes — any adaptation must carry the same licence |
How to credit this work
Mudassir Lawal; Neeta Raj Sharma; Awadhesh Kumar Verma; Gurmeen Rakhra (2025). Molecular modeling and identification of flax microgreens lignans as novel prostate cancer target inhibitors. Journal of Applied Biology & Biotechnology. https://doi.org/10.7324/JABB.2025.205522 Licensed under Creative Commons Attribution NC SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Hosted by EVEC Athens (microgreens.org.gr). No changes were made to this article. Provided as-is, without warranties. EVEC Athens is not affiliated with, and this copy is not endorsed by, the authors or the publisher.
Explore this on our site
- Related reading: Protein rich microgreens pea lentil chickpea and sunflower
- Related reading: Solanaceae lectins and alkaloids the compounds that make some microgreens toxic
- Related reading: Toxic microgreens the most recent toxicity cases found in studies and home grown crops
- Related reading: Microgreens the future of urban agriculture and superfoods part i
About this copy
This is a copy of the published article, hosted by EVEC Athens for free educational use under its open licence. The permanent scientific reference is the DOI above. We have not altered the file in any way. If you are an author or rights holder and want this copy removed, please use our notice and takedown procedure. We acknowledge every request within five working days, and act within ten.
Co-funded by the European Union.
This portal presents the microgreens methodology; the organisation behind it is EVEC Athens — the European Voluntary and Educational Center (evec.org.gr). Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.
Open licence. Except where stated otherwise, the educational materials on this portal are licensed under CC BY 4.0 — free to use, adapt and share, including commercially, with credit. See the licence terms.
Accessibility. We aim for WCAG 2.1 AA and publish what does and does not yet meet it — see the accessibility statement. If anything here blocks you, tell us and we will send the material in a format that works for you.